A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. on behalf of investors who purchased or acquired WGS common stock between April 16, 2025, and May 4, 2026. The lawsuit, filed in the United States District Court for the District of Connecticut, alleges that the company made materially false and misleading statements regarding the viability of its acquisition of Fabric Genomics. GeneDx had announced the acquisition on April 16, 2025, in a deal worth up to $51 million, touting Fabric's AI-driven genomic interpretation platform as a source of scalable recurring revenue. On May 4, 2026, the company disclosed a $31.3 million impairment loss directly attributable to Fabric, representing nearly the entire upfront cash consideration, and its share price fell more than 49%. Investors have until August 3, 2026, to seek lead plaintiff status.
GeneDx Holdings Corp.Securities fraud class action lawsuit alleging false statements about Fabric Genomics acquisition
ServiceNow Inc